Retraction: Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1

Frontiers in Pharmacology 2026 Open access

Read full text
Authors: Frontiers Editorial Office
DOI: 10.3389/fphar.2026.1791496
Cited by: 0

Abstract

[This retracts the article DOI: 10.3389/fphar.2024.1345645.].

Fields of Study & Subjects

Medicinal Plant Research HER2/EGFR in Cancer Research Natural Compound Pharmacology Studies

Publication details

Journal / source
Frontiers in Pharmacology
Volume
17
Pages
1791496–1791496
Publication date
29 January 2026
Language
EN